Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
470-10-149 ISMRM Abstract

Dark Band Sign on Preoperative T2-Weighted Imaging Predicts Survival After Surgery in Patients with Glioblastoma

Primary: Neuro - Tumors
Secondary: Neuro - Head & Neck/ENT
470-10-149 · Integrated MRI-Based Approaches for Preoperative Diagnosis, Grading, and Prognostic Prediction of Brain Tumors · Tuesday, 12 May, 4:55 PM–5:50 PM · Traditional Posters | Exhibition Hall
Keywords: Disease-free survival Glioblastoma MRI Prognosis T2-weighted imaging
Accepted
Ying Zhang1,2, Siheng Liu1, Dongcun Huang3, Zhenqiang He4, Wanming Hu5, Sheng Zhong4, Yanchun Lv1, Yonggao Mou4
1Department of Radiology, Sun yat-sen university cancer center, Guangzhou, China
2Department of Diagnostic Radiology, The University of Hong Kong, Hong Kong, China
3Department of Minimally Invasive Intervention, Sun yat-sen university cancer center, Guangzhou, China
4Department of Neurosurgery, Sun yat-sen university cancer center, Guangzhou, China
5Department of Pathology, Sun yat-sen university cancer center, Guangzhou, China
Presenting Author: PEI CAI

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Ostrom QT, Cioffi G, Gittleman H et al (2019) CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016. Neuro Oncol 21:v1-v100
2. McKinnon C, Nandhabalan M, Murray SA, Plaha P (2021) Glioblastoma: clinical presentation, diagnosis, and management. Bmj 374:n1560
3. Stupp R, Taillibert S, Kanner A et al (2017) Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial. Jama 318:2306-2316
4. Schaff LR, Mellinghoff IK (2023) Glioblastoma and Other Primary Brain Malignancies in Adults: A Review. Jama 329:574-587
5. Wen PY, Weller M, Lee EQ et al (2020) Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions. Neuro Oncol 22:1073-1113
6. Tan AC, Ashley DM, López GY, Malinzak M, Friedman HS, Khasraw M (2020) Management of glioblastoma: State of the art and future directions. CA Cancer J Clin 70:299-312
7. Burth S, Kickingereder P, Eidel O et al (2016) Clinical parameters outweigh diffusion- and perfusion-derived MRI parameters in predicting survival in newly diagnosed glioblastoma. Neuro Oncol 18:1673-1679
8. Gilbert MR, Wang M, Aldape KD et al (2013) Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial. J Clin Oncol 31:4085-4091
9. Gilbert MR, Wang M, Aldape KD et al (2013) Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial. J Clin Oncol 31:4085-4091
10. Pope WB, Sayre J, Perlina A, Villablanca JP, Mischel PS, Cloughesy TF (2005) MR imaging correlates of survival in patients with high-grade gliomas. AJNR Am J Neuroradiol 26:2466-2474
11. Lacroix M, Abi-Said D, Fourney DR et al (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:190-198
12. Bakas S, Akbari H, Sotiras A et al (2017) Advancing The Cancer Genome Atlas glioma MRI collections with expert segmentation labels and radiomic features. Sci Data 4:170117
13. Choi Y, Jang J, Kim BS, Ahn KJ (2023) Pretreatment MR-based radiomics in patients with glioblastoma: A systematic review and meta-analysis of prognostic endpoints. Eur J Radiol 168:111130
14. Moya-Sáez E, Navarro-González R, Cepeda S et al (2022) Synthetic MRI improves radiomics-based glioblastoma survival prediction. NMR Biomed 35:e4754
15. Lemée JM, Clavreul A, Menei P (2015) Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone. Neuro Oncol 17:1322-1332
16. He L, Zhang H, Li T et al (2024) Distinguishing Tumor Cell Infiltration and Vasogenic Edema in the Peritumoral Region of Glioblastoma at the Voxel Level via Conventional MRI Sequences. Acad Radiol 31:1082-1090
17. Eidel O, Burth S, Neumann JO et al (2017) Tumor Infiltration in Enhancing and Non-Enhancing Parts of Glioblastoma: A Correlation with Histopathology. PLoS One 12:e0169292
18. Park JK, Hodges T, Arko L et al (2010) Scale to predict survival after surgery for recurrent glioblastoma multiforme. J Clin Oncol 28:3838-3843
19. Hammoud MA, Sawaya R, Shi W, Thall PF, Leeds NE (1996) Prognostic significance of preoperative MRI scans in glioblastoma multiforme. J Neurooncol 27:65-73
20. Pérez-Beteta J, Molina-García D, Ortiz-Alhambra JA et al (2018) Tumor Surface Regularity at MR Imaging Predicts Survival and Response to Surgery in Patients with Glioblastoma. Radiology 288:218-225

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/470-10-149